John Hays
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, John Hays sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).
John Hays: 3 sponsored US clinical trials, none currently recruiting.
John Hays sponsors 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 2 completed. 0 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Signet Ring Adenocarcinoma of the Rectum, with 1 trials.
Upper-quartile sponsor footprint
John Hays sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
3 total, page 1 of 1
Nivolumab in Preventing Colon Adenomas in Participants With Lynch Syndrome and a History of Partial Colectomy
NCT03631641
Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab
NCT01814501
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
NCT01652196
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
How the John Hays early-phase archive is shaped
3 indexed studies, none listed as recruiting (0% open); 2 completed (67%).
Phase mix: 0 late (III/IV) vs 3 early (I/II) (early-phase heavy).
Top condition: Signet Ring Adenocarcinoma of the Rectum (1 trial), 7 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
John Hays: archived-pipeline peers nationwide
Peers matched on 3 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
John Hays sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 3 archived trials
- 10xBio · 3 trials · 0% recruiting
- 22nd Century Group · 3 trials · 0% recruiting
- AA Secord · 3 trials · 0% recruiting
- AAADRS Clinical Research Center · 3 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
- 3 Waves Wellness · 0% recruiting · 2 trials
- 3EO Health · 0% recruiting · 2 trials
Related
What to do with this John Hays page
3 registered trials is a research-attention snapshot, not an endorsement of John Hays or any single study.
- None of John Hays's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Signet Ring Adenocarcinoma of the Rectum is the condition John Hays studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Signet Ring Adenocarcinoma of the Rectum trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
John Hays pipeline card: 3 registered trials from official public datasets.Report a data error.